Literature DB >> 18179834

Measuring and illustrating statistical evidence in a cost-effectiveness analysis.

Jeffrey S Hoch1, Jeffrey D Blume.   

Abstract

Recently, there has been much interest in using the cost-effectiveness acceptability curve (CEAC) to measure the statistical evidence of cost-effectiveness. The CEAC has two well established but fundamentally different interpretations: one frequentist and one Bayesian. As an alternative, we suggest characterizing the statistical evidence about cost-effectiveness using the likelihood function (the key element of both approaches). Its interpretation is neither dependent on the sample space nor on the prior distribution. Moreover, the probability of observing misleading evidence is low and controllable, so this approach is justifiable in the traditional sense of frequentist long-run behaviour. We propose a new graphic for displaying the evidence about cost-effectiveness and explore the strengths of likelihood methods using data from an economic evaluation of a Program in Assertive Community Treatment (PACT).

Entities:  

Mesh:

Year:  2007        PMID: 18179834     DOI: 10.1016/j.jhealeco.2007.07.002

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  7 in total

1.  Using parametric multipoint lods and mods for linkage analysis requires a shift in statistical thinking.

Authors:  Susan E Hodge; Zeynep Baskurt; Lisa J Strug
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

2.  A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents.

Authors:  Peter G Szilagyi; Christina Albertin; Sharon G Humiston; Cynthia M Rand; Stanley Schaffer; Howard Brill; Joseph Stankaitis; Byung-Kwang Yoo; Aaron Blumkin; Shannon Stokley
Journal:  Acad Pediatr       Date:  2013-01-09       Impact factor: 3.107

3.  Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses.

Authors:  Dirk Müller; Eleanor Pullenayegum; Afschin Gandjour
Journal:  Eur J Health Econ       Date:  2014-05-20

Review 4.  Methodological concerns with economic evaluations of meningococcal vaccines.

Authors:  Teresa L Kauf
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Net benefit separation and the determination curve: A probabilistic framework for cost-effectiveness estimation.

Authors:  Andrew J Spieker; Nicholas Illenberger; Jason A Roy; Nandita Mitra
Journal:  Stat Methods Med Res       Date:  2021-04-07       Impact factor: 3.021

6.  Applying the net-benefit framework for analyzing and presenting cost-effectiveness analysis of a maternal and newborn health intervention.

Authors:  Sennen Hounton; David Newlands
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

7.  Applying the net-benefit framework for assessing cost-effectiveness of interventions towards universal health coverage.

Authors:  Sennen Hounton; David Newlands
Journal:  Cost Eff Resour Alloc       Date:  2012-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.